Do specific virus-bacteria pairings drive clinical outcomes of pneumonia?
1Department of Pediatrics, University of Tennessee Health Sciences Center, Memphis, TN 38103, USA. jmccullers@uthsc.edu
Abstract:
Bacterial pneumonia is a common contributor to severe outcomes of influenza. Epidemiological data suggest that the incidence, severity and associated bacterial pathogens differ between epidemics and by geographical location within epidemics. Data from animal models demonstrate that differences in both viral and bacterial strains alter the incidence and outcomes of pneumonia. For influenza viruses, evolutionary changes to specific virulence factors appear to alter the ability of viruses within particular lineages to prime the host for secondary bacterial infection. Although bacterial strains differ considerably in disease potential in the setting of viral co-infection, the bacterial virulence factors underlying this finding are currently unknown. The hypothesis that geographical variation exists in the prevalence of bacterial strains expressing factors that enable efficient disease potentiation during viral epidemics should be considered as one explanation for regional differences in severity. This would have implications for surveillance, vaccine development, and the conduct of clinical trials for the prevention or treatment of pneumonia.
Insights
Bacterial pneumonia following influenza is influenced by varying viral and bacterial strains. Geographical differences in bacterial strains may explain regional variations in pneumonia severity during flu epidemics.
Area of Science:
- Infectious Diseases
- Microbiology
- Epidemiology
Background:
- Bacterial pneumonia frequently complicates influenza, leading to severe outcomes.
- Epidemiological data indicate variability in pneumonia incidence, severity, and causative bacterial pathogens across different influenza epidemics and geographical locations.
- Animal models confirm that both viral and bacterial strain variations impact pneumonia incidence and outcomes.
Purpose of the Study:
- To explore the influence of viral and bacterial strain evolution on secondary bacterial pneumonia following influenza.
- To investigate the unknown bacterial virulence factors contributing to differential disease potential during viral co-infection.
- To consider the hypothesis that geographical variation in bacterial strains influences pneumonia severity during influenza epidemics.
Main Methods:
- Review of epidemiological data on influenza-associated bacterial pneumonia.
- Analysis of findings from animal models examining viral-bacterial interactions.
- Hypothetical consideration of geographical variation in bacterial virulence factors.
Main Results:
- Evolutionary changes in influenza virus virulence factors can alter host susceptibility to secondary bacterial infection.
- Bacterial strains exhibit differing disease potentials in the context of viral co-infection, though underlying factors are not fully understood.
- Geographical variations in bacterial strains expressing specific virulence factors may contribute to regional differences in pneumonia severity.
Conclusions:
- Understanding viral and bacterial strain dynamics is crucial for addressing influenza-associated bacterial pneumonia.
- Geographical variation in bacterial virulence factors is a plausible explanation for regional differences in pneumonia severity.
- These findings have significant implications for public health surveillance, vaccine development, and clinical trial design for pneumonia prevention and treatment.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
10:47Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
Published on: April 14, 2011
Related Concept Videos
01:29Pneumonia I: Introduction
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia III: Complications and Assessment
01:14Atypical Pneumonia